Dr. Albers’ primary research focus is the diagnosis, management, and prevention of ischemic stroke. Dr. Albers and his team use advanced imaging technology to expand the treatment window for ischemic stroke, thereby improving patient health and quality of life outcomes. Dr. Albers conducts clinical studies of treatments for acute stroke, including both thrombolytic strategies (which dissolve blood clots) and neuroprotective strategies (which seek to limit neuronal damage). He also investigates new antithrombotic strategies for stroke prevention. Dr. Albers was instrumental in the development of medical software, RAPID, that interprets patient brain scans and helps clinicians decide on appropriate treatments for ischemic stroke. A prolific researcher, Dr. Albers has authored more than 500 articles on topics related to cerebrovascular disease in peer-reviewed journals.